Alivus Life Sciences Limited has informed the Exchange about Weblink of Recording of Earnings Call Q2 FY2026.
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences Limited has submitted a web link to the Exchange containing the audio/video recording of its Q2 FY2026 earnings call. This is a routine regulatory disclosure following the conclusion of the company's quarterly results call with analysts and investors. The filing itself does not contain any financial figures, guidance, or management commentary. Investors who wish to hear the full management discussion on quarterly performance and outlook would need to access the provided recording link.
This is a procedural disclosure with no direct impact on the stock price. It improves transparency by allowing shareholders and analysts to revisit the management commentary from the Q2 FY2026 earnings call at their convenience.